au.\*:("CROZIER, Ian G")
Results 1 to 7 of 7
Selection :
Effects of Omapatrilat on systemic arterial function in patients with chronic heart failureMCCLEAN, Dougal R; IKRAM, Hamid; GARLICK, Amanda H et al.The American journal of cardiology. 2001, Vol 87, Num 5, pp 565-569, issn 0002-9149Article
Antecedent hypertension and Heart failure after myocardial infarctionRICHARDS, A. Mark; NICHOLLS, M. Gary; TROUGHTON, Richard W et al.Journal of the American College of Cardiology. 2002, Vol 39, Num 7, pp 1182-1188, issn 0735-1097Article
An Entirely Subcutaneous Implantable Cardioverter-DefibrillatorBARDY, Gust H; SMITH, Warren M; FYNN, Simon P et al.The New England journal of medicine. 2010, Vol 363, Num 1, pp 36-44, issn 0028-4793, 9 p.Article
B-Type natriuretic peptides and ejection fraction for prognosis after myocardial infarctionRICHARDS, A. Mark; NICHOLLS, M. Gary; ESPINER, Eric A et al.Circulation (New York, N.Y.). 2003, Vol 107, Num 22, pp 2786-2792, issn 0009-7322, 7 p.Article
The performance of high sensitivity troponin for the diagnosis of acute myocardial infarction is underestimatedALDOUS, Sally J; FLORKOWSKI, Chris M; CROZIER, Ian G et al.Clinical chemistry and laboratory medicine. 2012, Vol 50, Num 4, pp 727-729, issn 1434-6621, 3 p.Article
Direct Left Atrial Pressure Monitoring in Ambulatory Heart Failure Patients : Initial Experience With a New Permanent Implantable DeviceRITZEMA, Jay; MELTON, Iain C; ABRAHAM, William T et al.Circulation (New York, N.Y.). 2007, Vol 116, Num 25, pp 2952-2959, issn 0009-7322, 8 p.Article
Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease. CommentaryRICHARDS, Mark; NICHOLLS, M. Gary; MACMAHON, Stephen et al.Journal of the American College of Cardiology. 2006, Vol 47, Num 1, pp 52-64, issn 0735-1097, 13 p.Article